ProCE Banner Activity

Can 2-Drug Regimens be Used for Rapid-Start ART?

Clinical Thought
The STAT study suggests we might be able to use 2-drug ART for rapid start, but in my own practice, I’m hesitant until we have more studies.

Released: November 29, 2021

Expiration: November 28, 2022

No longer available for credit.

Share

Faculty

Jason Halperin

Jason Halperin, MD, MPH, FIDSA

Director of Specialty Program
DAP Health
Cathedral City, California

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Jason Halperin, MD, MPH, FIDSA

Director of Specialty Program
DAP Health
Cathedral City, California

Jason Halperin, MD, MPH, has no relevant conflicts of interest to report.